Relationship between the prevalence of anti-glutamic acid decarboxylase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients

Relationship between the prevalence of anti-glutamic acid decarboxylase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients

The objective of the present study was to determine whether the duration of disease has any influence on the prevalence of glutamic acid decarboxylase autoantibodies (GADA) in Brazilian patients with type 1 diabetes (T1D) and variable disease duration. We evaluated 83 patients with T1D. All particip...

Full description

Bibliographic Details
Main Authors:	M. Rodacki, L. Zajdenverg, M.S. Albernaz, M.R. Bencke-Gonçalves, A. Milech, J.E.P. Oliveira
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2004-11-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Anti-GAD65 auto-antibodies Type 1 diabetes mellitus Time from diagnosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004001100008

Similar Items

Pengaruh Kerja Shift terhadap Kadar Glutamic Acid Decarboxylase 65 (GAD65) dalam Serum Darah
by: Imam Cahyo Murwidi
Published: (2018-05-01)

Reducing glutamic acid decarboxylase in the dorsal dentate gyrus attenuates juvenile stress induced emotional and cognitive deficits
by: Kuldeep Tripathi, et al.
Published: (2021-11-01)

Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
by: Elias S. Siraj, et al.
Published: (2018-02-01)

The range of neurological syndromes associated with glutamic acid decarboxylase antibodies
by: M. Yu. Krasnov, et al.
Published: (2017-02-01)

Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders
by: Ravi Rajmohan, et al.
Published: (2024-01-01)

Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)

Human Leukocyte Antigens class II influence the expression of Glutamic Acid Decarboxylase auto antibodies in Type Diabetic children and their Siblings
by: Eman Mahdi Saleh
Published: (2010-06-01)

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies
by: Suvi Liimatainen, et al.
Published: (2018-04-01)

The Role of GAD65 Autoantibody in Diabetes Mellitus and their First-Degree Relatives and Comparison with Healthy Persons
by: M Nakhjavani, et al.
Published: (2001-06-01)

Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review
by: Niels Hansen, et al.
Published: (2022-02-01)

FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus
by: Yu-Ling Gan, et al.
Published: (2022-06-01)

GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female Siblings
by: Joseph Kuchling, et al.
Published: (2014-11-01)

A Simple and Efficient Method for the Substrate Identification of Amino Acid Decarboxylases
by: Mingyu Fang, et al.
Published: (2022-11-01)

Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series
by: Maurício Fernandes, et al.
Published: (2012-09-01)

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1
by: Shenghua Zong, et al.
Published: (2023-05-01)

Molecular Analysis of Glutamate Decarboxylases in Enterococcus avium
by: Xinyi Gu, et al.
Published: (2021-09-01)

GAD‐65 antibodies in a case of HNF1A‐Maturity‐Onset Diabetes of the Young: Double diabetes?
by: Åke Sjöholm
Published: (2021-06-01)

Atypical parkinsonism and intrathecal anti-glutamic acid decarboxylase antibodies – an unusual association: a case report
by: Giovanni Stefanoni, et al.
Published: (2020-06-01)

Autoimmune meningoencephalitis associated with anti‐glutamic acid decarboxylase antibody following COVID‐19 infection: A case report
by: Mehri Salari, et al.
Published: (2022-12-01)

GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study)
by: Sine Knorr, et al.
Published: (2022-01-01)

Exploring the contributions of two glutamate decarboxylase isozymes in Lactobacillus brevis to acid resistance and γ-aminobutyric acid production
by: Changjiang Lyu, et al.
Published: (2018-11-01)

Enhancing Bioremediation Potential of Pseudomonas putida by Developing Its Acid Stress Tolerance With Glutamate Decarboxylase Dependent System and Global Regulator of Extreme Radiation Resistance
by: Zikang Zhou, et al.
Published: (2019-09-01)

Prospects of antigen-specific therapy in type 1 diabetes mellitus
by: Tatiana Vasil'evna Nikonova, et al.
Published: (2012-12-01)

Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes
by: Erika Bolneo, et al.
Published: (2022-07-01)

Stereological Estimates of Glutamatergic, GABAergic, and Cholinergic Neurons in the Pedunculopontine and Laterodorsal Tegmental Nuclei in the Rat
by: Esther Luquin, et al.
Published: (2018-05-01)

Loss of Glutamate Decarboxylase 67 in Somatostatin-Expressing Neurons Leads to Anxiety-Like Behavior and Alteration in the Akt/GSK3β Signaling Pathway
by: Shigeo Miyata, et al.
Published: (2019-06-01)

The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy
by: Ju-Yin Hou, et al.
Published: (2023-02-01)

Interactions of human autoantibodies with hippocampal GABAergic synaptic transmission – analyzing antibody-induced effects ex-vivo
by: Holger eHaselmann, et al.
Published: (2015-06-01)

Seizure semiology and predictors of outcomes in Chinese patients with glutamic acid decarboxylase antibody-associated neurological syndrome
by: Nan Lin, et al.
Published: (2023-04-01)

Correlation of Mothers with History of Diabetes Mellitus and Infants with Anti-GAD65
by: Nanda Fadhilah Witris Salamy, et al.
Published: (2021-01-01)

Konfirmasi spesifitas GAD65 terhadap anti-GAD65 pada tikus DM dan pasien DM tipe 1
by: Aulanniâ€™a Aulanniâ€™a, et al.
Published: (2012-02-01)

Glutamic acid decarboxylase 67 expression by a distinct population of mouse vestibular supporting cells
by: Giancarlo eRusso, et al.
Published: (2014-12-01)

Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes
by: Henrik Hill, et al.
Published: (2021-12-01)

Impact of Dysfunctional Feed-Forward Inhibition on Glutamate Decarboxylase Isoforms and γ-Aminobutyric Acid Transporters
by: Sandesh Panthi, et al.
Published: (2021-07-01)

Laminar Distribution of Subsets of GABAergic Axon Terminals in Human Prefrontal Cortex
by: Kenneth N. Fish, et al.
Published: (2018-02-01)

Genetic characteristics and β-cell Autoimmunity in T1DM Children
by: Eman M. Saleh, et al.
Published: (2008-01-01)

γ-Aminobutyric acid is involved in overlapping pathways against chilling injury by modulating glutamate decarboxylase and defense responses in papaya fruit
by: Ghulam Khaliq, et al.
Published: (2023-11-01)

Corrigendum: Glutamic acid decarboxylase 67 expression by a distinct population of mouse vestibular supporting cells
by: Simona eTritto, et al.
Published: (2015-04-01)

Weak Association Between the Glutamate Decarboxylase 1 Gene (GAD1) and Schizophrenia in Han Chinese Population
by: Luwen Zhang, et al.
Published: (2021-06-01)

Mesomere-derived glutamate decarboxylase-expressing blastocoelar mesenchyme cells of sea urchin larvae
by: Hideki Katow, et al.
Published: (2013-12-01)